← Open Payments lookup

KAREN KASCHAK: Open Payments

NPI 1013078906 · CAPE MAY COURT HOUSE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,951 in 100 payments from 14 companies in 2025. Trend: 2023 $1,463 · 2024 $1,653 · 2025 $1,951

Food & beverage: $1,851Education: $100
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.18$372
Alkermes, Inc.11$292
Teva Pharmaceuticals USA, Inc.15$266
Lundbeck LLC16$237
E.R. Squibb & Sons, L.L.C.14$199
Otsuka America Pharmaceutical, Inc.9$186
ANI Pharmaceuticals, Inc.1$115
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$84
Axsome Therapeutics, Inc.4$69
Vanda Pharmaceuticals Inc.2$36

Products named: INGREZZA, REXULTI, COBENFY, AUSTEDO XR, ARISTADA, LYBALVI, PURIFIED CORTROPHIN GEL, CAPLYTA.

Industry payments across NJ — which companies pay providers there.